{
    "medicine_id": "a1c0c2f54c50c3e3ccdde25a534c072b1f8fdc14",
    "platform_id": "DB00199",
    "metadata": {
        "name": "Akne mycin 20 mg 1g Ointment",
        "composition": "20 mg 1g Erythromycin",
        "clinical_particulars": {
            "therapeutic_indications": "Erythromycin is indicated in the treatment of infections caused by susceptible strains of various bacteria L7261 The indications for erythromycin have been summarized by body system below Respiratory infections Mild to moderate upper respiratory tract infections caused by Streptococcus pyogenes Streptococcus pneumoniae or Haemophilus influenzae when used concomitantly with appropriate doses of sulfonamides can be treated with erythromycin L7261 Mild to moderate lower respiratory tract infections due to susceptible strains of Streptococcus pneumoniae or Streptococcus pyogenes may also be treated Erythromycin treats listeriosis caused by Listeria monocytogenes may also be treated with erythromycin L7261 Erythromycin is indicated to treat pertussis whooping cough caused by Bordetella pertussis It is effective in eliminating the causative organism from the nasopharynx of infected individuals rendering them noninfectious Clinical studies suggest that erythromycin may aid in the prevention of pertussis infection for individuals who have been exposed to the bacteria L7261 Respiratory tract infections due to Mycoplasma pneumoniae may also be treated with erythromycin L7261 Despite the fact that no controlled clinical efficacy studies have been conducted to this date in vitro and certain preliminary clinical study results indicate that erythromycin may be an effective treatment in Legionnaires Disease L7261 Finally erythromycin is indicated to treat diphtheria and other infections due to Corynebacterium diphtheriae as an adjunct to antitoxin to prevent carrier status and to eradicate the organism in existing carriers L7261 In addition to the prevention of diphtheria erythromycin can be used to prevent rheumatic fever in penicillin intolerant patients L7261 Skin infections Mild to moderate skin or skin structure infections caused by Streptococcus pyogenes or Staphylococcus aureus may be treated with erythromycin however resistant staphylococcal organisms may emerge L7261 Erythromycin can also be used to treat erythrasma an infectious condition caused by Corynebacterium minutissimum L7261 Gastrointestinal infections Intestinal amebiasis caused by Entamoeba histolytica can be treated with oral erythromycin Extraenteric amebiasis warrants treatment with other antimicrobial drugs L7261 Genital infections STIs Erythromycin can be used as an alternative drug in treating acute pelvic inflammatory disease caused by N gonorrheae in female patients who have demonstrated hypersensitivity or intolerance to penicillin L7261 Syphilis caused by Treponema pallidum can be treated with erythromycin It serves as an alternative treatment for primary syphilis in patients who have demonstrated penicillin hypersensitivity Erythromycin can also be used in the primary stage of primary syphilis L7261 Another approved indication of erythromycin is to treat chlamydial infections that cause conjunctivitis of the newborn pneumonia of infancy and urogenital infections occurring in pregnancy It is indicated as an alternative option to tetracyclines for the treatment of uncomplicated rectal urethral and endocervical infections in adults caused by Chlamydia trachomatis L7261 Erythromycin can be used in nongonococcal urethritis can be used when tetracyclines cannot be administered Finally erythromycin is indicated to treat nongonococcal urethritis due to Ureaplasma urealyticum L7261",
            "contraindications": {
                "disease": "LD50 The oral LD50 of erythromycin in rats is 9272 mg kg L7279 Overdose information Symptoms of overdose may include diarrhea nausea stomach cramps and vomiting Erythromycin should immediately be discontinued in cases of overdose Rapid elimination of unabsorbed drug should be attempted Supportive measures should be initiated Erythromycin is not adequately removed by peritoneal dialysis or hemodialysis L7261",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Macrolides such as erythromycin stop bacterial growth by inhibiting protein synthesis and translation treating bacterial infections A174175 Erythromycin does not exert effects on nucleic acid synthesis L7261 This drug has been shown to be active against most strains of the following microorganisms effectively treating both in vitro and clinical infections Despite this it is important to perform bacterial susceptibility testing before administering this antibiotic as resistance is a common issue that may affect treatment L7261 A note on antimicrobial resistance pseudomembranous colitis and hepatotoxicity Many strains of Haemophilus influenzae are resistant to erythromycin alone but are found to be susceptible to erythromycin and sulfonamides used in combination It is important to note that Staphylococci that are resistant to erythromycin may emerge during erythromycin and or sulfonamide therapy L7261 Pseudomembranous colitis has been reported with most antibacterial agents including erythromycin and may range in severity from mild to life threatening Therefore the physician should consider this diagnosis in patients with diarrhea after the administration of antibacterial agents L7261 Erythromycin can cause hepatic dysfunction cholestatic jaundice and abnormal liver transaminases particularly when erythromycin estolate is administered L7270",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB08916",
                        "description": "The serum concentration of Afatinib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The serum concentration of Bosutinib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB02123",
                        "description": "Erythromycin may decrease the excretion rate of Glycochenodeoxycholic Acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00222",
                        "description": "Erythromycin may decrease the excretion rate of Glimepiride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00275",
                        "description": "Erythromycin may decrease the excretion rate of Olmesartan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00301",
                        "description": "Erythromycin may decrease the excretion rate of Flucloxacillin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "Erythromycin may decrease the excretion rate of Atenolol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "Erythromycin may decrease the excretion rate of Rosiglitazone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "Erythromycin may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00693",
                        "description": "Erythromycin may decrease the excretion rate of Fluorescein which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00698",
                        "description": "Erythromycin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "Erythromycin may decrease the excretion rate of Naproxen which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "Erythromycin may decrease the excretion rate of Disulfiram which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00833",
                        "description": "Erythromycin may decrease the excretion rate of Cefaclor which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00911",
                        "description": "Erythromycin may decrease the excretion rate of Tinidazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "Erythromycin may decrease the excretion rate of Glipizide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "Erythromycin may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09374",
                        "description": "Erythromycin may decrease the excretion rate of Indocyanine green acid form which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12319",
                        "description": "Erythromycin may decrease the excretion rate of Benzbromarone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13751",
                        "description": "Erythromycin may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00973",
                        "description": "Erythromycin may decrease the excretion rate of Ezetimibe which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "Diethylstilbestrol may decrease the excretion rate of Erythromycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "Indomethacin may decrease the excretion rate of Erythromycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "Diclofenac may decrease the excretion rate of Erythromycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "Nefazodone may decrease the excretion rate of Erythromycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "Atazanavir may decrease the excretion rate of Erythromycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "Erythromycin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00455",
                        "description": "Erythromycin may decrease the excretion rate of Loratadine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "Erythromycin may decrease the excretion rate of Losartan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "Erythromycin may decrease the excretion rate of Telmisartan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "Erythromycin may decrease the excretion rate of Fenofibrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15719",
                        "description": "Erythromycin may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The serum concentration of Edoxaban can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "The serum concentration of Ledipasvir can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09049",
                        "description": "The serum concentration of Naloxegol can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The serum concentration of Pazopanib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Ranolazine can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06207",
                        "description": "The serum concentration of Silodosin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The serum concentration of Topotecan can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The metabolism of Brexpiprazole can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The metabolism of Eliglustat can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The metabolism of Everolimus can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Flibanserin"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The metabolism of Ibrutinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09083",
                        "description": "The metabolism of Ivabradine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08820",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Ivacaftor"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The metabolism of Lurasidone can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The metabolism of Olaparib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09143",
                        "description": "The metabolism of Sonidegib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The serum concentration of Alfentanil can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01076",
                        "description": "The serum concentration of Atorvastatin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06237",
                        "description": "The metabolism of Avanafil can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The metabolism of Carbamazepine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The serum concentration of Cisapride can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "Erythromycin may increase the QTc prolonging activities of Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "The metabolism of Eplerenone can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "The serum concentration of Estazolam can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00950",
                        "description": "Erythromycin can cause an increase in the absorption of Fexofenadine resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "Fluconazole may increase the QTc prolonging and arrhythmogenic activities of Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The serum concentration of Lovastatin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The risk or severity of ventricular arrhythmias and torsade de pointes can be increased when Erythromycin is combined with Mequitazine"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Erythromycin is combined with Pimozide"
                    },
                    {
                        "drugbank-id": "DB08860",
                        "description": "The serum concentration of Pitavastatin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00175",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be increased when Erythromycin is combined with Pravastatin"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Quinidine"
                    },
                    {
                        "drugbank-id": "DB00912",
                        "description": "The serum concentration of Repaglinide can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01220",
                        "description": "The serum concentration of Rifaximin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The serum concentration of Rilpivirine can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The metabolism of Sildenafil can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The serum concentration of Simvastatin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The metabolism of Sirolimus can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The metabolism of Temsirolimus can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The serum concentration of Terfenadine can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The serum concentration of Triazolam can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00549",
                        "description": "The serum concentration of Zafirlukast can be decreased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The metabolism of Cilostazol can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The metabolism of Colchicine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The metabolism of Fentanyl can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The metabolism of Iloperidone can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01256",
                        "description": "The metabolism of Retapamulin can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08895",
                        "description": "The metabolism of Tofacitinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The metabolism of Eszopiclone can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The metabolism of Zopiclone can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The metabolism of Alfuzosin can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The metabolism of Alprazolam can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08735",
                        "description": "The serum concentration of R S Warfarin alcohol can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08736",
                        "description": "The serum concentration of S R Warfarin alcohol can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The serum concentration of Midazolam can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The serum concentration of Tacrolimus can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB05521",
                        "description": "The serum concentration of Telaprevir can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09272",
                        "description": "The serum concentration of Eluxadoline can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09268",
                        "description": "The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The excretion of Vincristine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB05168",
                        "description": "The serum concentration of Vintafolide can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "The serum concentration of Vincamine can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00511",
                        "description": "The serum concentration of Acetyldigitoxin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01078",
                        "description": "The serum concentration of Deslanoside can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01092",
                        "description": "The serum concentration of Ouabain can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12843",
                        "description": "The serum concentration of Oleandrin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13240",
                        "description": "The serum concentration of Cymarin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13307",
                        "description": "The serum concentration of Proscillaridin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13467",
                        "description": "The serum concentration of Lanatoside C can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13537",
                        "description": "The serum concentration of Gitoformate can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13756",
                        "description": "The serum concentration of Peruvoside can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The metabolism of Cyclosporine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "The serum concentration of Doxofylline can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The serum concentration of Doxorubicin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01627",
                        "description": "The therapeutic efficacy of Erythromycin can be decreased when used in combination with Lincomycin"
                    },
                    {
                        "drugbank-id": "DB11537",
                        "description": "The therapeutic efficacy of Erythromycin can be decreased when used in combination with Pirlimycin"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Isradipine"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Trimethadione"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Lamotrigine"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Cinnarizine"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Nicardipine"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Magnesium sulfate"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Zonisamide"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Nitrendipine"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Nifedipine"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Nimesulide"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04838",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Cyclandelate"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Flunarizine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Methsuximide"
                    },
                    {
                        "drugbank-id": "DB05885",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Seletracetam"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Nylidrin"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Ziconotide"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Dotarizine"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Xylometazoline"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Tranilast"
                    },
                    {
                        "drugbank-id": "DB08162",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Fasudil"
                    },
                    {
                        "drugbank-id": "DB08838",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Agmatine"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Fendiline"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Trimebutine"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Pinaverium"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Tolfenamic acid"
                    },
                    {
                        "drugbank-id": "DB09227",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Barnidipine"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Aranidipine"
                    },
                    {
                        "drugbank-id": "DB09230",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Azelnidipine"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Benidipine"
                    },
                    {
                        "drugbank-id": "DB09232",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Cilnidipine"
                    },
                    {
                        "drugbank-id": "DB09234",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Darodipine"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Efonidipine"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Lacidipine"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Manidipine"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Niguldipine"
                    },
                    {
                        "drugbank-id": "DB09240",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Niludipine"
                    },
                    {
                        "drugbank-id": "DB11960",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Carboxyamidotriazole"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Naftopidil"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Vinpocetine"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Gallopamil"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Bencyclane"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Otilonium"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Lidoflazine"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB13835",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Caroverine"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with WIN 55212 2"
                    },
                    {
                        "drugbank-id": "DB13961",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Fish oil"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB14064",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Emopamil"
                    },
                    {
                        "drugbank-id": "DB14065",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Lomerizine"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Tetrandrine"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Carvedilol"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Ethosuximide"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Sotalol"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Procainamide"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Bepridil"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Goserelin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Moxifloxacin"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Promazine"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Prochlorperazine"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Droperidol"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Perflutren"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Atropine"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Adenosine"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Pentamidine"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Gadobenic acid"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Carbinoxamine"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Dolasetron"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Roxithromycin"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Nalidixic acid"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Cinoxacin"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Granisetron"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Papaverine"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Flecainide"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Probucol"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Terlipressin"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Azimilide"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Pracinostat"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Tedisamil"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Tucidinostat"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Telavancin"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Antazoline"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Bedaquiline"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Melperone"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Simendan"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Lorcainide"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Dexchlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Propafenone"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Emedastine"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Encorafenib"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The risk or severity of QTc prolongation can be increased when Esmolol is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The risk or severity of QTc prolongation can be increased when Galantamine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of QTc prolongation can be increased when Moricizine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of QTc prolongation can be increased when Indapamide is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Famotidine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of QTc prolongation can be increased when Felbamate is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of QTc prolongation can be increased when Formoterol is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of QTc prolongation can be increased when Desipramine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of QTc prolongation can be increased when Desflurane is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "The risk or severity of QTc prolongation can be increased when Encainide is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "The risk or severity of QTc prolongation can be increased when Cariporide is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Degarelix is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Buserelin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Histrelin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Eribulin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The risk or severity of QTc prolongation can be increased when Indenolol is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Flumequine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Famphur is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Fenthion is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Phosmet is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Bilastine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when CUDC 907 is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Temefos is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Givinostat is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of QTc prolongation can be increased when Inotersen is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The risk or severity of QTc prolongation can be increased when Timolol is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of QTc prolongation can be increased when Propofol is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of QTc prolongation can be increased when Promethazine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxepin is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Ebastine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The metabolism of Lorazepam can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The metabolism of Phentermine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Ticlopidine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00426",
                        "description": "The metabolism of Famciclovir can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "The metabolism of Cephalexin can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01411",
                        "description": "The metabolism of Pranlukast can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "The metabolism of Allylestrenol can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01656",
                        "description": "The metabolism of Roflumilast can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The metabolism of Rufinamide can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The metabolism of Lacosamide can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "The metabolism of Tasimelteon can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11094",
                        "description": "The metabolism of Vitamin D can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12515",
                        "description": "The metabolism of 9 aminocamptothecin can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12952",
                        "description": "The metabolism of Methylprednisone can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The metabolism of Medical Cannabis can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Drospirenone"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The metabolism of St John s Wort can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06717",
                        "description": "The metabolism of Fosaprepitant can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "The metabolism of Tenofovir alafenamide can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The metabolism of Azithromycin can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The metabolism of Metoprolol can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The metabolism of Duloxetine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00518",
                        "description": "The metabolism of Albendazole can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The metabolism of Doxazosin can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "The metabolism of Suvorexant can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The metabolism of Netupitant can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The metabolism of Meperidine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The metabolism of Isavuconazole can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01303",
                        "description": "The metabolism of Oxtriphylline can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13203",
                        "description": "The metabolism of Bamifylline can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13573",
                        "description": "The metabolism of Acefylline can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13812",
                        "description": "The metabolism of Bufylline can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01482",
                        "description": "The metabolism of Fenethylline can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13449",
                        "description": "The metabolism of Proxyphylline can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB14018",
                        "description": "The metabolism of Bromotheophylline can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "The metabolism of Pentoxifylline can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01667",
                        "description": "The metabolism of 8 azaguanine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01978",
                        "description": "The metabolism of 7 9 Dimethylguanine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB02134",
                        "description": "The metabolism of Xanthine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB02245",
                        "description": "The metabolism of 7 Deazaguanine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB02377",
                        "description": "The metabolism of Guanine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB02489",
                        "description": "The metabolism of 9 Methylguanine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB02568",
                        "description": "The metabolism of Peldesine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB04076",
                        "description": "The metabolism of Hypoxanthine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB04356",
                        "description": "The metabolism of 9 Deazaguanine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06575",
                        "description": "The metabolism of Valomaciclovir can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB07954",
                        "description": "The metabolism of 3 isobutyl 1 methyl 7H xanthine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08844",
                        "description": "The metabolism of Uric acid can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11919",
                        "description": "The metabolism of 6 O benzylguanine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12406",
                        "description": "The metabolism of Lisofylline can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12531",
                        "description": "The metabolism of Lobucavir can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12926",
                        "description": "The metabolism of Cafedrine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "The metabolism of Theodrenaline can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13592",
                        "description": "The metabolism of Etamiphylline can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13634",
                        "description": "The metabolism of Pentifylline can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB14029",
                        "description": "The metabolism of Furafylline can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01412",
                        "description": "The metabolism of Theobromine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06479",
                        "description": "The metabolism of Propentofylline can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00201",
                        "description": "The metabolism of Caffeine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB14132",
                        "description": "The metabolism of 8 chlorotheophylline can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "The metabolism of Mercaptopurine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB15122",
                        "description": "The metabolism of PCS 499 can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB05239",
                        "description": "The metabolism of Cobimetinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12768",
                        "description": "The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB14022",
                        "description": "The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The serum concentration of Betrixaban can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "The serum concentration of Rosuvastatin can be decreased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "The excretion of Erythromycin can be increased when combined with Apalutamide"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Erythromycin may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Erythromycin can be decreased when it is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The serum concentration of Morphine can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00300",
                        "description": "The serum concentration of Tenofovir disoproxil can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The serum concentration of Clobazam can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "The serum concentration of Bisoprolol can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "The serum concentration of Mannitol can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00882",
                        "description": "The serum concentration of Clomifene can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The serum concentration of Tegaserod can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "The serum concentration of Sitagliptin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "The serum concentration of Ambrisentan can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06670",
                        "description": "The serum concentration of Odanacatib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The serum concentration of Linagliptin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08930",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08934",
                        "description": "The serum concentration of Sofosbuvir can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The serum concentration of Umeclidinium can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The serum concentration of Nintedanib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09161",
                        "description": "The serum concentration of Technetium Tc 99m sestamibi can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The serum concentration of Dasabuvir can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09296",
                        "description": "The serum concentration of Ombitasvir can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09297",
                        "description": "The serum concentration of Paritaprevir can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "The serum concentration of Selexipag can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11574",
                        "description": "The serum concentration of Elbasvir can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11575",
                        "description": "The serum concentration of Grazoprevir can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11613",
                        "description": "The serum concentration of Velpatasvir can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The serum concentration of Talinolol can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "The serum concentration of Ertugliflozin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11869",
                        "description": "The serum concentration of Valspodar can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11952",
                        "description": "The serum concentration of Duvelisib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The serum concentration of Elagolix can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11995",
                        "description": "The serum concentration of Avatrombopag can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12026",
                        "description": "The serum concentration of Voxilaprevir can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The serum concentration of Gilteritinib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The serum concentration of Rucaparib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12455",
                        "description": "The serum concentration of Omadacycline can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12836",
                        "description": "The serum concentration of Grapiprant can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13125",
                        "description": "The serum concentration of Lusutrombopag can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13878",
                        "description": "The serum concentration of Pibrentasvir can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13879",
                        "description": "The serum concentration of Glecaprevir can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "The serum concentration of Tenofovir can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB14723",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The serum concentration of Loperamide can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The serum concentration of Rifamycin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "The serum concentration of Fedratinib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13007",
                        "description": "The serum concentration of Enfortumab vedotin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12941",
                        "description": "The serum concentration of Darolutamide can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12887",
                        "description": "The serum concentration of Tazemetostat can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The serum concentration of Lasmiditan can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The serum concentration of Methylene blue can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The serum concentration of Tipranavir can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB14840",
                        "description": "The serum concentration of Ripretinib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The serum concentration of Belinostat can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB14761",
                        "description": "The serum concentration of Remdesivir can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The metabolism of Aripiprazole can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The metabolism of Aripiprazole lauroxil can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00446",
                        "description": "The therapeutic efficacy of Erythromycin can be decreased when used in combination with Chloramphenicol"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "The serum concentration of Dabigatran etexilate can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00177",
                        "description": "The excretion of Erythromycin can be decreased when combined with Valsartan"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "The excretion of Torasemide can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "The excretion of Penicillamine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00917",
                        "description": "The excretion of Dinoprostone can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01053",
                        "description": "The excretion of Benzylpenicillin can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06199",
                        "description": "The excretion of Atrasentan can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06721",
                        "description": "The excretion of Gimatecan can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08836",
                        "description": "The excretion of Temocapril can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08862",
                        "description": "The excretion of Cholecystokinin can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08884",
                        "description": "The excretion of Gadoxetic acid can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09137",
                        "description": "The excretion of Technetium Tc 99m mebrofenin can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09279",
                        "description": "The excretion of Fimasartan can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00345",
                        "description": "The excretion of Erythromycin can be decreased when combined with Aminohippuric acid"
                    },
                    {
                        "drugbank-id": "DB00583",
                        "description": "The excretion of Erythromycin can be decreased when combined with Levocarnitine"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The excretion of Erythromycin can be decreased when combined with Sulfasalazine"
                    },
                    {
                        "drugbank-id": "DB01051",
                        "description": "The excretion of Erythromycin can be decreased when combined with Novobiocin"
                    },
                    {
                        "drugbank-id": "DB01892",
                        "description": "The excretion of Erythromycin can be decreased when combined with Hyperforin"
                    },
                    {
                        "drugbank-id": "DB04850",
                        "description": "The excretion of Erythromycin can be decreased when combined with Posizolid"
                    },
                    {
                        "drugbank-id": "DB06151",
                        "description": "The excretion of Erythromycin can be decreased when combined with Acetylcysteine"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "The excretion of Erythromycin can be decreased when combined with Eltrombopag"
                    },
                    {
                        "drugbank-id": "DB08880",
                        "description": "The excretion of Erythromycin can be decreased when combined with Teriflunomide"
                    },
                    {
                        "drugbank-id": "DB09292",
                        "description": "The excretion of Erythromycin can be decreased when combined with Sacubitril"
                    },
                    {
                        "drugbank-id": "DB09298",
                        "description": "The excretion of Erythromycin can be decreased when combined with Silibinin"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "The excretion of Levosalbutamol can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01583",
                        "description": "The excretion of Liotrix can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "The excretion of Erythromycin can be decreased when combined with Gemfibrozil"
                    },
                    {
                        "drugbank-id": "DB01393",
                        "description": "The excretion of Erythromycin can be decreased when combined with Bezafibrate"
                    },
                    {
                        "drugbank-id": "DB09198",
                        "description": "The excretion of Erythromycin can be decreased when combined with Lobeglitazone"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "The excretion of Conjugated estrogens can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00481",
                        "description": "The excretion of Raloxifene can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00520",
                        "description": "The excretion of Caspofungin can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "The excretion of Enalapril can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "The excretion of Sumatriptan can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00213",
                        "description": "The excretion of Erythromycin can be decreased when combined with Pantoprazole"
                    },
                    {
                        "drugbank-id": "DB00602",
                        "description": "The excretion of Erythromycin can be decreased when combined with Ivermectin"
                    },
                    {
                        "drugbank-id": "DB01645",
                        "description": "The excretion of Erythromycin can be decreased when combined with Genistein"
                    },
                    {
                        "drugbank-id": "DB04216",
                        "description": "The excretion of Erythromycin can be decreased when combined with Quercetin"
                    },
                    {
                        "drugbank-id": "DB05928",
                        "description": "The excretion of Erythromycin can be decreased when combined with Dovitinib"
                    },
                    {
                        "drugbank-id": "DB13919",
                        "description": "The excretion of Erythromycin can be decreased when combined with Candesartan"
                    },
                    {
                        "drugbank-id": "DB11936",
                        "description": "The excretion of Erythromycin can be decreased when combined with Bempedoic acid"
                    },
                    {
                        "drugbank-id": "DB01264",
                        "description": "The excretion of Erythromycin can be decreased when combined with Darunavir"
                    },
                    {
                        "drugbank-id": "DB00197",
                        "description": "The risk or severity of liver damage can be increased when Troglitazone is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The risk or severity of liver damage can be increased when Erythromycin is combined with Reserpine"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "The risk or severity of liver damage can be increased when Erythromycin is combined with Progesterone"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of liver damage can be increased when Erythromycin is combined with Chlorpromazine"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The risk or severity of liver damage can be increased when Erythromycin is combined with Cimetidine"
                    },
                    {
                        "drugbank-id": "DB00559",
                        "description": "The risk or severity of liver damage can be increased when Erythromycin is combined with Bosentan"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "The risk or severity of liver damage can be increased when Erythromycin is combined with Ethinylestradiol"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "The risk or severity of liver damage can be increased when Erythromycin is combined with Glyburide"
                    },
                    {
                        "drugbank-id": "DB01586",
                        "description": "The risk or severity of liver damage can be increased when Erythromycin is combined with Ursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB02659",
                        "description": "The risk or severity of liver damage can be increased when Erythromycin is combined with Cholic Acid"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "The risk or severity of liver damage can be increased when Erythromycin is combined with Fusidic acid"
                    },
                    {
                        "drugbank-id": "DB06290",
                        "description": "The risk or severity of liver damage can be increased when Erythromycin is combined with Simeprevir"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of liver damage can be increased when Erythromycin is combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "The risk or severity of liver damage can be increased when Erythromycin is combined with Letermovir"
                    },
                    {
                        "drugbank-id": "DB14057",
                        "description": "The risk or severity of liver damage can be increased when Erythromycin is combined with Valinomycin"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The risk or severity of liver damage can be increased when Celecoxib is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB03619",
                        "description": "Deoxycholic acid may increase the excretion rate of Erythromycin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04348",
                        "description": "Taurocholic acid may increase the excretion rate of Erythromycin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "Erythromycin may decrease the excretion rate of Daunorubicin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The serum concentration of Romidepsin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The serum concentration of Digitoxin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The serum concentration of Etoposide can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The serum concentration of Dactinomycin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The serum concentration of Trastuzumab emtansine can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB05889",
                        "description": "The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The serum concentration of Cabazitaxel can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The serum concentration of Crizotinib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The serum concentration of Dabrafenib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The serum concentration of Ceritinib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09330",
                        "description": "The serum concentration of Osimertinib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11760",
                        "description": "The serum concentration of Talazoparib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The serum concentration of Dacomitinib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12483",
                        "description": "The serum concentration of Copanlisib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The serum concentration of Imipramine can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The serum concentration of Erythromycin can be increased when it is combined with Trimipramine"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "The serum concentration of Tolvaptan can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The serum concentration of Bendamustine can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The serum concentration of Carfilzomib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11967",
                        "description": "The serum concentration of Binimetinib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The serum concentration of Gemcitabine can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The serum concentration of Regorafenib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The serum concentration of Erythromycin can be increased when it is combined with Nortriptyline"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Erythromycin can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB11712",
                        "description": "The metabolism of Tezacaftor can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The metabolism of Vindesine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The metabolism of Vinorelbine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11641",
                        "description": "The metabolism of Vinflunine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Erlotinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The metabolism of Nilotinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The metabolism of Vandetanib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Bortezomib"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The metabolism of Vinblastine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The metabolism of Tamoxifen can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11703",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Acalabrutinib"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The metabolism of Panobinostat can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The metabolism of Ponatinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11581",
                        "description": "The metabolism of Venetoclax can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "The metabolism of Baricitinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The metabolism of Ivosidenib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The metabolism of Amiodarone can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The metabolism of Dasatinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12978",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Pexidartinib"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The metabolism of Fosphenytoin can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The metabolism of Cyclophosphamide can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The metabolism of Ifosfamide can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Midostaurin"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The metabolism of Dofetilide can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01008",
                        "description": "The metabolism of Busulfan can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01223",
                        "description": "The metabolism of Aminophylline can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The metabolism of Tianeptine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The metabolism of Axitinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Irinotecan"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The metabolism of Paclitaxel can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The metabolism of Docetaxel can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "The metabolism of Idelalisib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The metabolism of Methotrexate can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The metabolism of Teniposide can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The metabolism of Sunitinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12015",
                        "description": "The metabolism of Alpelisib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The metabolism of Clonidine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The metabolism of Astemizole can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The metabolism of Clomipramine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08827",
                        "description": "The metabolism of Lomitapide can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The metabolism of Thiotepa can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The metabolism of Trabectedin can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11363",
                        "description": "The metabolism of Alectinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB04845",
                        "description": "The metabolism of Ixabepilone can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "The metabolism of Ruxolitinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The metabolism of Palbociclib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09570",
                        "description": "The metabolism of Ixazomib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11828",
                        "description": "The metabolism of Neratinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The metabolism of Erdafitinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12267",
                        "description": "The metabolism of Brigatinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12001",
                        "description": "The metabolism of Abemaciclib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The metabolism of Conivaptan can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01128",
                        "description": "The metabolism of Bicalutamide can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The metabolism of Levacetylmethadol can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Nelfinavir"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Itraconazole"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB08873",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Boceprevir"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB13179",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Troleandomycin"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The metabolism of Ketoconazole can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The metabolism of Saquinavir can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06448",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Lonafarnib"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Voriconazole"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB12130",
                        "description": "The metabolism of Lorlatinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01126",
                        "description": "The metabolism of Dutasteride can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The metabolism of Istradefylline can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB04856",
                        "description": "The metabolism of Dexloxiglumide can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The metabolism of Fluvastatin can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB00238",
                        "description": "The metabolism of Nevirapine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00367",
                        "description": "The metabolism of Levonorgestrel can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The metabolism of Oxycodone can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00499",
                        "description": "The metabolism of Flutamide can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The metabolism of Oxybutynin can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06267",
                        "description": "The metabolism of Udenafil can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "The metabolism of Saxagliptin can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06419",
                        "description": "The metabolism of Cethromycin can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06652",
                        "description": "The metabolism of Vicriviroc can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06789",
                        "description": "The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "The metabolism of Perampanel can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The metabolism of Vortioxetine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11737",
                        "description": "The metabolism of Icotinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "The metabolism of Valbenazine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12301",
                        "description": "The metabolism of Doravirine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The metabolism of Nabiximols can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Delavirdine"
                    },
                    {
                        "drugbank-id": "DB02520",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Ditiocarb"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Safinamide"
                    },
                    {
                        "drugbank-id": "DB14635",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Curcumin sulfate"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The metabolism of Lemborexant can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00673",
                        "description": "The metabolism of Aprepitant can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "The metabolism of Tadalafil can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The metabolism of Cerivastatin can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "The metabolism of Mycophenolate mofetil can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Amprenavir"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Estradiol"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Fluticasone furoate"
                    },
                    {
                        "drugbank-id": "DB09102",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Daclatasvir"
                    },
                    {
                        "drugbank-id": "DB13867",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Fluticasone"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Estradiol acetate"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Estradiol benzoate"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Estradiol cypionate"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Estradiol dienanthate"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Estradiol valerate"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "The metabolism of Testosterone can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The metabolism of Asunaprevir can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The metabolism of Phenytoin can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "The metabolism of Lidocaine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "The metabolism of Gefitinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The metabolism of Amitriptyline can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The metabolism of Methadone can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The metabolism of Propranolol can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The metabolism of Chloroquine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The metabolism of Risperidone can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "The metabolism of Clopidogrel can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The metabolism of Diazepam can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The metabolism of Metronidazole can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "The metabolism of Buprenorphine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01103",
                        "description": "The metabolism of Quinacrine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The metabolism of Quetiapine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The metabolism of Enzalutamide can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "The metabolism of Testosterone cypionate can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "The metabolism of Testosterone enanthate can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "The metabolism of Testosterone undecanoate can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "The metabolism of Indinavir can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "The metabolism of Nisoldipine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The metabolism of Felodipine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Clofazimine"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The metabolism of Hydrocortisone butyrate can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00655",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Estrone"
                    },
                    {
                        "drugbank-id": "DB14542",
                        "description": "The metabolism of Hydrocortisone phosphate can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "The metabolism of Tegafur can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11837",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Osilodrostat"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The metabolism of Erythromycin can be increased when combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB00745",
                        "description": "The metabolism of Erythromycin can be increased when combined with Modafinil"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The metabolism of Erythromycin can be increased when combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "The metabolism of Erythromycin can be increased when combined with Beclomethasone dipropionate"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The metabolism of Erythromycin can be increased when combined with Thalidomide"
                    },
                    {
                        "drugbank-id": "DB06413",
                        "description": "The metabolism of Erythromycin can be increased when combined with Armodafinil"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "The metabolism of Erythromycin can be increased when combined with Oxcarbazepine"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "The metabolism of Erythromycin can be increased when combined with Fluprednidene"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "The metabolism of Erythromycin can be increased when combined with Dexamethasone isonicotinate"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "The metabolism of Erythromycin can be increased when combined with Mometasone furoate"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The metabolism of Erythromycin can be increased when combined with Prednisolone phosphate"
                    },
                    {
                        "drugbank-id": "DB14633",
                        "description": "The metabolism of Erythromycin can be increased when combined with Prednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14644",
                        "description": "The metabolism of Erythromycin can be increased when combined with Methylprednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14646",
                        "description": "The metabolism of Erythromycin can be increased when combined with Prednisone acetate"
                    },
                    {
                        "drugbank-id": "DB14652",
                        "description": "The metabolism of Erythromycin can be increased when combined with Clocortolone acetate"
                    },
                    {
                        "drugbank-id": "DB14659",
                        "description": "The metabolism of Erythromycin can be increased when combined with Melengestrol acetate"
                    },
                    {
                        "drugbank-id": "DB14669",
                        "description": "The metabolism of Erythromycin can be increased when combined with Betamethasone phosphate"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "The metabolism of Erythromycin can be increased when combined with Clobetasol propionate"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "The metabolism of Erythromycin can be increased when combined with Fluocinonide"
                    },
                    {
                        "drugbank-id": "DB00764",
                        "description": "The metabolism of Erythromycin can be increased when combined with Mometasone"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "The metabolism of Erythromycin can be increased when combined with Fluocortolone"
                    },
                    {
                        "drugbank-id": "DB11750",
                        "description": "The metabolism of Erythromycin can be increased when combined with Clobetasol"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "The metabolism of Erythromycin can be increased when combined with Difluocortolone"
                    },
                    {
                        "drugbank-id": "DB00250",
                        "description": "The metabolism of Dapsone can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "The metabolism of Dextromethorphan can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00717",
                        "description": "The metabolism of Norethisterone can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "The metabolism of Nateglinide can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The metabolism of Tretinoin can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "The metabolism of Zaleplon can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01058",
                        "description": "The metabolism of Praziquantel can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01216",
                        "description": "The metabolism of Finasteride can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB05804",
                        "description": "The metabolism of Prasterone sulfate can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB14539",
                        "description": "The metabolism of Hydrocortisone acetate can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB14541",
                        "description": "The metabolism of Hydrocortisone cypionate can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Phenelzine"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB06412",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Oxymetholone"
                    },
                    {
                        "drugbank-id": "DB06730",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Gestodene"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The metabolism of Erythromycin can be decreased when combined with Seproxetine"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "The metabolism of Erythromycin can be increased when combined with Rifampicin"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "The excretion of Liothyronine can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09142",
                        "description": "The excretion of Sincalide can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB05016",
                        "description": "The excretion of Erythromycin can be decreased when combined with Ataluren"
                    },
                    {
                        "drugbank-id": "DB06749",
                        "description": "The excretion of Erythromycin can be decreased when combined with Ginsenoside Rb1"
                    },
                    {
                        "drugbank-id": "DB00646",
                        "description": "The excretion of Erythromycin can be decreased when combined with Nystatin"
                    },
                    {
                        "drugbank-id": "DB11942",
                        "description": "The excretion of Erythromycin can be decreased when combined with Selinexor"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "The excretion of Erythromycin can be decreased when combined with Levothyroxine"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "Erythromycin may decrease the excretion rate of Revefenacin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The metabolism of Erythromycin can be increased when combined with Etanercept"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The metabolism of Erythromycin can be increased when combined with Anakinra"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The metabolism of Erythromycin can be increased when combined with Adalimumab"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The metabolism of Erythromycin can be increased when combined with Infliximab"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The metabolism of Erythromycin can be increased when combined with Abatacept"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The metabolism of Erythromycin can be increased when combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The metabolism of Erythromycin can be increased when combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The metabolism of Erythromycin can be increased when combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The metabolism of Erythromycin can be increased when combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The metabolism of Erythromycin can be increased when combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The metabolism of Erythromycin can be increased when combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The metabolism of Erythromycin can be increased when combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The metabolism of Erythromycin can be increased when combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The metabolism of Erythromycin can be increased when combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The metabolism of Erythromycin can be increased when combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "The serum concentration of Erythromycin can be increased when it is combined with Prucalopride"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The serum concentration of Digoxin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The risk or severity of adverse effects can be increased when Erythromycin is combined with Verapamil"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "The risk or severity of adverse effects can be increased when Erythromycin is combined with Amlodipine"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The risk or severity of adverse effects can be increased when Erythromycin is combined with Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "Erythromycin may increase the vasoconstricting activities of Methysergide"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "Erythromycin may increase the vasoconstricting activities of Cabergoline"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "Erythromycin may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00353",
                        "description": "Erythromycin may increase the vasoconstricting activities of Methylergometrine"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "Erythromycin may increase the vasoconstricting activities of Lisuride"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "Erythromycin may increase the vasoconstricting activities of Ergotamine"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "Erythromycin may increase the vasoconstricting activities of Nicergoline"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "Erythromycin may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "Erythromycin may increase the vasoconstricting activities of Pergolide"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "Erythromycin may increase the vasoconstricting activities of Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "Erythromycin may increase the vasoconstricting activities of Ergometrine"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "Erythromycin may increase the vasoconstricting activities of Lysergic acid diethylamide"
                    },
                    {
                        "drugbank-id": "DB11273",
                        "description": "Erythromycin may increase the vasoconstricting activities of Dihydroergocornine"
                    },
                    {
                        "drugbank-id": "DB13345",
                        "description": "Erythromycin may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13385",
                        "description": "Erythromycin may increase the vasoconstricting activities of Dihydroergocryptine"
                    },
                    {
                        "drugbank-id": "DB13399",
                        "description": "Erythromycin may increase the vasoconstricting activities of Terguride"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "Erythromycin may increase the vasoconstricting activities of Metergoline"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "The risk or severity of adverse effects can be increased when Erythromycin is combined with Metildigoxin"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of adverse effects can be increased when Erythromycin is combined with Acetyldigoxin"
                    },
                    {
                        "drugbank-id": "DB00546",
                        "description": "The serum concentration of Adinazolam can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The therapeutic efficacy of Erythromycin can be decreased when used in combination with Theophylline"
                    },
                    {
                        "drugbank-id": "DB00581",
                        "description": "The therapeutic efficacy of Lactulose can be decreased when used in combination with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "The risk or severity of adverse effects can be increased when Erythromycin is combined with Siponimod"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The serum concentration of Erythromycin can be increased when it is combined with Deflazacort"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The serum concentration of Vardenafil can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00001",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Lepirudin"
                    },
                    {
                        "drugbank-id": "DB00006",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Bivalirudin"
                    },
                    {
                        "drugbank-id": "DB00009",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Alteplase"
                    },
                    {
                        "drugbank-id": "DB00013",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Urokinase"
                    },
                    {
                        "drugbank-id": "DB00015",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Reteplase"
                    },
                    {
                        "drugbank-id": "DB00029",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Anistreplase"
                    },
                    {
                        "drugbank-id": "DB00031",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Tenecteplase"
                    },
                    {
                        "drugbank-id": "DB00054",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00055",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Drotrecogin alfa"
                    },
                    {
                        "drugbank-id": "DB00086",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Streptokinase"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Dicoumarol"
                    },
                    {
                        "drugbank-id": "DB00278",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Argatroban"
                    },
                    {
                        "drugbank-id": "DB00407",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Ardeparin"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Phenindione"
                    },
                    {
                        "drugbank-id": "DB00569",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Fondaparinux"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Warfarin"
                    },
                    {
                        "drugbank-id": "DB00686",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Pentosan polysulfate"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Acetylsalicylic acid"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Phenprocoumon"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Dipyridamole"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Iloprost"
                    },
                    {
                        "drugbank-id": "DB01109",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Heparin"
                    },
                    {
                        "drugbank-id": "DB01225",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Enoxaparin"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Acenocoumarol"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Coumarin"
                    },
                    {
                        "drugbank-id": "DB04898",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Ximelagatran"
                    },
                    {
                        "drugbank-id": "DB04925",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Desmoteplase"
                    },
                    {
                        "drugbank-id": "DB04932",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Defibrotide"
                    },
                    {
                        "drugbank-id": "DB05099",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Ancrod"
                    },
                    {
                        "drugbank-id": "DB05229",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Beraprost"
                    },
                    {
                        "drugbank-id": "DB05254",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Fibrinolysin"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Prasugrel"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Rivaroxaban"
                    },
                    {
                        "drugbank-id": "DB06271",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Sulodexide"
                    },
                    {
                        "drugbank-id": "DB06294",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Semuloparin"
                    },
                    {
                        "drugbank-id": "DB06406",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Idraparinux"
                    },
                    {
                        "drugbank-id": "DB06441",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Cangrelor"
                    },
                    {
                        "drugbank-id": "DB06543",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Astaxanthin"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Apixaban"
                    },
                    {
                        "drugbank-id": "DB06635",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Otamixaban"
                    },
                    {
                        "drugbank-id": "DB06679",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Amediplase"
                    },
                    {
                        "drugbank-id": "DB06754",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Danaparoid"
                    },
                    {
                        "drugbank-id": "DB06779",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Dalteparin"
                    },
                    {
                        "drugbank-id": "DB06822",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Tinzaparin"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Ferulic acid"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with R warfarin"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Ethyl biscoumacetate"
                    },
                    {
                        "drugbank-id": "DB08813",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Nadroparin"
                    },
                    {
                        "drugbank-id": "DB08814",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Triflusal"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Ticagrelor"
                    },
                    {
                        "drugbank-id": "DB08994",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Ditazole"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Vorapaxar"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Potassium citrate"
                    },
                    {
                        "drugbank-id": "DB09154",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Sodium citrate"
                    },
                    {
                        "drugbank-id": "DB09255",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Dextran"
                    },
                    {
                        "drugbank-id": "DB09258",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Bemiparin"
                    },
                    {
                        "drugbank-id": "DB09260",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Parnaparin"
                    },
                    {
                        "drugbank-id": "DB11095",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Desirudin"
                    },
                    {
                        "drugbank-id": "DB11154",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Zinc citrate"
                    },
                    {
                        "drugbank-id": "DB11166",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Antithrombin Alfa"
                    },
                    {
                        "drugbank-id": "DB11312",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Protein C"
                    },
                    {
                        "drugbank-id": "DB11598",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Antithrombin III human"
                    },
                    {
                        "drugbank-id": "DB11984",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Letaxaban"
                    },
                    {
                        "drugbank-id": "DB12289",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Darexaban"
                    },
                    {
                        "drugbank-id": "DB12598",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12726",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Monteplase"
                    },
                    {
                        "drugbank-id": "DB12831",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Gabexate"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Fluindione"
                    },
                    {
                        "drugbank-id": "DB13149",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13199",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Brinase"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB13616",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Melagatran"
                    },
                    {
                        "drugbank-id": "DB13646",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Saruplase"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with S Warfarin"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB14598",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Edetate calcium disodium anhydrous"
                    },
                    {
                        "drugbank-id": "DB14726",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Dabigatran"
                    },
                    {
                        "drugbank-id": "DB13124",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Troxerutin"
                    },
                    {
                        "drugbank-id": "DB00974",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Edetic acid"
                    },
                    {
                        "drugbank-id": "DB09259",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Reviparin"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The serum concentration of Buspirone can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB05154",
                        "description": "The serum concentration of Pretomanid can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The metabolism of Entrectinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Erythromycin may increase the QTc prolonging activities of Lefamulin"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "Triamcinolone may decrease the excretion rate of Erythromycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The serum concentration of Dronedarone can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The serum concentration of Salmeterol can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB15444",
                        "description": "The serum concentration of Elexacaftor can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB15035",
                        "description": "The metabolism of Zanubrutinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB14975",
                        "description": "The serum concentration of Voxelotor can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Cenobamate can be decreased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "The serum concentration of Levamlodipine can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB06077",
                        "description": "The serum concentration of Lumateperone can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB15328",
                        "description": "The serum concentration of Ubrogepant can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The metabolism of Tramadol can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01190",
                        "description": "The therapeutic efficacy of Erythromycin can be decreased when used in combination with Clindamycin"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB12457",
                        "description": "The serum concentration of Rimegepant can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00126",
                        "description": "The therapeutic efficacy of Erythromycin can be decreased when used in combination with Ascorbic acid"
                    },
                    {
                        "drugbank-id": "DB08830",
                        "description": "The therapeutic efficacy of Erythromycin can be decreased when used in combination with Dehydroascorbic acid"
                    },
                    {
                        "drugbank-id": "DB11352",
                        "description": "The therapeutic efficacy of Erythromycin can be decreased when used in combination with Ascorbyl phosphate"
                    },
                    {
                        "drugbank-id": "DB14482",
                        "description": "The therapeutic efficacy of Erythromycin can be decreased when used in combination with Sodium ascorbate"
                    },
                    {
                        "drugbank-id": "DB14483",
                        "description": "The therapeutic efficacy of Erythromycin can be decreased when used in combination with Calcium ascorbate"
                    },
                    {
                        "drugbank-id": "DB14485",
                        "description": "The therapeutic efficacy of Erythromycin can be decreased when used in combination with Zinc ascorbate"
                    },
                    {
                        "drugbank-id": "DB14486",
                        "description": "The therapeutic efficacy of Erythromycin can be decreased when used in combination with Niacinamide ascorbate"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The serum concentration of Erythromycin can be increased when it is combined with Cortisone acetate"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The serum concentration of Erythromycin can be increased when it is combined with Paramethasone"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The serum concentration of Erythromycin can be increased when it is combined with Meprednisone"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The serum concentration of Erythromycin can be increased when it is combined with Cortivazol"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The serum concentration of Erythromycin can be increased when it is combined with Prednylidene"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The serum concentration of Erythromycin can be increased when it is combined with Cloprednol"
                    },
                    {
                        "drugbank-id": "DB14681",
                        "description": "The serum concentration of Erythromycin can be increased when it is combined with Cortisone"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The serum concentration of Erythromycin can be increased when it is combined with Budesonide"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The serum concentration of Hydrocortisone can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The serum concentration of Dexamethasone can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "The serum concentration of Erythromycin can be increased when it is combined with Prednisone"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The serum concentration of Erythromycin can be increased when it is combined with Betamethasone"
                    },
                    {
                        "drugbank-id": "DB00180",
                        "description": "The serum concentration of Flunisolide can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00687",
                        "description": "The serum concentration of Fludrocortisone can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The serum concentration of Prednisolone can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The serum concentration of Methylprednisolone can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01108",
                        "description": "The serum concentration of Trilostane can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB01285",
                        "description": "The serum concentration of Corticotropin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB04630",
                        "description": "The serum concentration of Aldosterone can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB09378",
                        "description": "The serum concentration of Fluprednisolone can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11529",
                        "description": "The serum concentration of Melengestrol can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Erythromycin can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Haloperidol"
                    },
                    {
                        "drugbank-id": "DB05990",
                        "description": "The risk or severity of adverse effects can be increased when Erythromycin is combined with Obeticholic acid"
                    },
                    {
                        "drugbank-id": "DB14443",
                        "description": "The therapeutic efficacy of Vibrio cholerae CVD 103 HgR strain live antigen can be decreased when used in combination with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11689",
                        "description": "The serum concentration of Selumetinib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The metabolism of Tucatinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB15102",
                        "description": "The metabolism of Pemigatinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB12674",
                        "description": "The serum concentration of Lurbinectedin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Erythromycin can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The serum concentration of Oliceridine can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Erythromycin can be decreased when it is combined with Satralizumab"
                    },
                    {
                        "drugbank-id": "DB15822",
                        "description": "The serum concentration of Erythromycin can be increased when it is combined with Pralsetinib"
                    },
                    {
                        "drugbank-id": "DB14845",
                        "description": "The serum concentration of Erythromycin can be increased when it is combined with Filgotinib"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The serum concentration of Berotralstat can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Erythromycin"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}